---
$id: https://graph.org.ai/products/commodity/51332701
$type: Product
source: UNSPSC
code: "51332701"
title: "Batelapine"
class: "51332700"
classTitle: "Antipsychotic dibenzazepines"
family: "51330000"
familyTitle: "Antipsychotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Batelapine

**UNSPSC Code**: 51332701
**Class**: [Antipsychotic dibenzazepines](Antipsychotic dibenzazepines.mdx)
**Family**: [Antipsychotics](../Antipsychotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antipsychotic agent with the molecular formula C16H20N6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, P71TE299SG chemically known as 11h-(1,2,4)triazolo(1,5-c)(1,3)benzodiazepine, 2-methyl-5-(4-methyl-1-piperazinyl)- but generally known as batelapine, which bears US NIH Compound Identifier 60717. European Medicines Agency schedules Batelapine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06110MIG. The term BATELAPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, no. 3 1991, list 31. ). Most nations schedule batelapine under HS 29335995 and SITC 51576. As of Q4 2014, BATELAPINE remains the US FDA Preferred Term for this commodity. Batelapine bears US NLM identifiers UMLS ID C0165561 and NCI Concept Code C76436. SMILES: CC1=NN2C(=N1)CC3=CC=CC=C3N=C2N4CCN(CC4)C.

